ISSCR iPSC-derived cell therapies
We are sponsoring this event!
Come and visit our team at our stand to discuss how bit.bio offers partnering opportunities that affords access to the most relevant parental human cell types and corresponding disease models. These models are physiologically relevant and highly characterised, offering predictive, in vitro, human cells for early drug discovery, phenotypic screening, and high-content imaging applications.
More information coming soon!Arrange a meeting